Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
aTyr Pharma, Inc. - Common Stock
(NQ:
ATYR
)
5.830
+0.275 (+4.95%)
Official Closing Price
Updated: 4:15 PM EDT, Jul 25, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about aTyr Pharma, Inc. - Common Stock
< Previous
1
2
Next >
aTyr Pharma Announces Appointment of Jayant Aphale, PhD, as Vice President of Technical Operations
August 06, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
aTyr Pharma Announces Research Study with Stanford Medicine
July 30, 2024
Study to explore role of the Company’s anti-NRP2 antibodies in glioblastoma multiforme (GBM), the most common type of primary brain cancer.
From
aTyr Pharma, Inc.
Via
GlobeNewswire
Super League Enterprise And 2 Other Stocks Under $2 Insiders Are Buying
July 25, 2024
Via
Benzinga
aTyr Pharma Completes Enrollment in Global Pivotal Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis
July 22, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
ATYR Stock Earnings: aTyr Pharma Beats EPS for Q2 2023
June 10, 2024
ATYR stock results show that aTyr Pharma beat analyst estimates for earnings per share the second quarter of 2023.
Via
InvestorPlace
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.